Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial.

Sharma, Abhinav; Ferreira, João Pedro; Zannad, Faiez; Pocock, Stuart J; Filippatos, Gerasimos; Pfarr, Egon; Petrini, Michaela; Kraus, Bettina J; Wanner, Christoph; Packer, Milton; +2 more... Butler, Javed; Anker, Stefan D; (2023) Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial. European journal of heart failure, 25 (8). pp. 1337-1348. ISSN 1388-9842 DOI: https://doi.org/10.1002/ejhf.2857

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/ejhf.2857

Abstract

Share

Download

Filename: Sharma-etal-2023-Cardiac-and-kidney-benefits-of.pdf

Licence: Creative Commons: Attribution-Noncommercial 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar